ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MED Intelligent Ultrasound Group Plc

14.50
0.00 (0.00%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Intelligent Ultrasound Group Plc LSE:MED London Ordinary Share GB00BN791Q39 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 14.50 14.00 15.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Medaphor Group PLC Patent Infringement Settlement (0517S)

16/12/2016 7:24am

UK Regulatory


Intelligent Ultrasound (LSE:MED)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Intelligent Ultrasound Charts.

TIDMMED

RNS Number : 0517S

Medaphor Group PLC

16 December 2016

MedaPhor Group plc

("the Group" the "Company")

Patent Infringement Settlement

Further to the statement made by the Company on 27 April 2016 (RNS No. 4638W: Notice of Patent Infringement Proceedings), the Group subsidiaries, MedaPhor Limited and MedaPhor North America Inc. (collectively "MedaPhor"), announce that MedaPhor and SonoSim Inc. and The Regents of the University of California have reached an agreement in principle on a patent license and patent infringement settlement. As a result, the parties will proceed to formalize their agreement in writing, following which the lawsuit between the parties will be dismissed.

The settlement will be satisfied from the existing cash resources of the Group. The Company will provide a further update on the settlement once all documents are finalised.

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulations which came into effect on 3 July 2016.

Enquiries:

 
 MedaPhor Group plc                                                    www.medaphor.com 
 Stuart Gall, CEO                                              Tel: +44 (0)29 2075 6534 
 
 Cenkos Securities                                             Tel: +44 (0)20 7397 8900 
 Bobbie Hilliam (Nominated 
  Adviser) 
 Julian Morse (Corporate Broking) 
 
 Walbrook PR                        Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com 
 Paul McManus / Anna Dunphy                         Mob: +44 (0)7980 541 893 / Mob: +44 
                                                                        (0)7876 741 001 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCGGGPPPUPQUMQ

(END) Dow Jones Newswires

December 16, 2016 02:24 ET (07:24 GMT)

1 Year Intelligent Ultrasound Chart

1 Year Intelligent Ultrasound Chart

1 Month Intelligent Ultrasound Chart

1 Month Intelligent Ultrasound Chart

Your Recent History

Delayed Upgrade Clock